Plain-English translation of NCT07154719 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing how , a newer weight-loss medication, affects your muscles and bones when you lose weight. Researchers want to understand whether losing weight with this medication causes problems like muscle loss or bone weakening—something that has raised concerns with similar drugs. You'll be randomly assigned to either take the medication with a special lifestyle program, or take the medication with standard diet and exercise guidance.
While this medication helps people lose weight and manage diabetes very effectively, doctors have noticed that weight loss itself—and this medication specifically—might cause people to lose too much muscle and bone mass, which could increase injury and disability risk. This trial will clarify exactly how much these changes occur and help doctors protect patients' overall health.
You likely qualify if…
You likely don't qualify if…
You will receive injections for 5 months while researchers track changes to your muscle and bone using special scans (like a DXA scan and MRI). Depending on which group you're randomly assigned to, you'll either follow a structured lifestyle toolkit program or receive standard diet and exercise guidance. You'll have several clinic visits over the 6-month study period, including blood tests, body composition measurements, and questionnaires to monitor your health.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States